18 Apr 2017
To take the pharmaceutical manufacturing industry further, faster, GEA has invested in a new multimillion-Euro solid dosage facility. In May this year, the company will officially open its recently expanded GEA Pharma Solids Center (GPSC) in Wommelgem, Belgium.
With a total footprint of 1100 m2, including 200 m2 of technical space, GEA’s investment in its Wommelgem facility embodies the state-of-the-art in solid dosage form testing, development and optimization. Now almost tripled in size, the GPSC offers a full range of batch and continuous process technologies to produce pharmaceutical solid dosage forms.
Some of the key application areas will include continuous wet granulation and drying technologies, continuous direct compression, integrated small-scale granulation and drying, flexible fluid bed processing, high performance tablet coating technology, and the ability to optimize pellet and MUPS formulations. The GPSC will offer extensive customer demonstrations and trials, training sessions, hands-on lab experience, product development assistance, CQA evaluation support and updates on what can be achieved with GEA process solutions and equipment.